Analysts Recommendations AMTEK, Inc.(NYSE:AME): Ironwood Pharmaceuticals, Inc.(NASDAQ:IRWD)

0
5

AMTEK, Inc. (AME) will report its next earnings on May 01 BMO. The company reported the earnings of $1/Share in the last quarter where the estimated EPS by analysts was $0.97/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 3.1%.

Many analysts are providing their Estimated Earnings analysis for AMTEK, Inc. and for the current quarter 14 analysts have projected that the stock could give an Average Earnings estimate of $1.02/share. These analysts have also projected a Low Estimate of $1.01/share and a High Estimate of $1.03/share.

In case of Revenue Estimates, 13 analysts have provided their consensus Average Revenue Estimates for AMTEK, Inc. as 1.32 Billion. According to these analysts, the Low Revenue Estimate for AMTEK, Inc. is 1.28 Billion and the High Revenue Estimate is 1.34 Billion. The company had Year Ago Sales of 1.21 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for AME to be 22.9%. They are projecting Next Quarter growth of 23.17%. For the next 5 years, AMTEK, Inc. is expecting Growth of 6.9% per annum, whereas in the past 5 years the growth was 23.71% per annum.

Some buy side analysts are also providing their Analysis on AMTEK, Inc., where 3 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 1 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for AMTEK, Inc. might touch $105 high while the Average Price Target and Low price Target is $95.71 and $87 respectively.

AMTEK, Inc. closed its last trading session at $84.11 with the gain of 1.08%. The Market Capitalization of the company stands at 19.34 Billion. The Company has 52-week high of $88.76 and 52-week low of $63.14. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -1.54% where SMA50 and SMA200 are 1.7% and 11.08% respectively. The Company Touched its 52-Week High on 05/01/19 and 52-Week Low on 12/26/18.

The Relative Volume of the company is 0.81 and Average Volume (3 months) is 1.1 million. The company’s P/E (price to earnings) ratio is 24.95 and Forward P/E ratio of 19.75.

The company shows its Return on Assets (ROA) value of 9.5%. The Return on Equity (ROE) value stands at 18.3%. While it’s Return on Investment (ROI) value is 12.4%.

While looking at the Stock’s Performance, AMTEK, Inc. currently shows a Weekly Performance of -0.51%, where Monthly Performance is -0.92%, Quarterly performance is 9.93%, 6 Months performance is 13.41% and yearly performance percentage is 13.65%. Year to Date performance value (YTD perf) value is 25.58%. The Stock currently has a Weekly Volatility of 1.90% and Monthly Volatility of 1.48%.

Ironwood Pharmaceuticals, Inc. (IRWD) will report its next earnings on May 02 BMO. The company reported the earnings of $-0.26/Share in the last quarter where the estimated EPS by analysts was $-0.14/share. The difference between the expected and actual EPS was $-0.12/share, which represents an Earnings surprise of -85.7%.

Many analysts are providing their Estimated Earnings analysis for Ironwood Pharmaceuticals, Inc. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.06/share. These analysts have also projected a Low Estimate of $-0.16/share and a High Estimate of $0.06/share.

In case of Revenue Estimates, 6 analysts have provided their consensus Average Revenue Estimates for Ironwood Pharmaceuticals, Inc. as 89.16 Million. According to these analysts, the Low Revenue Estimate for Ironwood Pharmaceuticals, Inc. is 87 Million and the High Revenue Estimate is 92.22 Million. The company had Year Ago Sales of 81.11 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for IRWD to be 71.4%. They are projecting Next Quarter growth of 121.05%. For the next 5 years, Ironwood Pharmaceuticals, Inc. is expecting Growth of 434.19% per annum, whereas in the past 5 years the growth was 85.26% per annum.

Some buy side analysts are also providing their Analysis on Ironwood Pharmaceuticals, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Ironwood Pharmaceuticals, Inc. might touch $19 high while the Average Price Target and Low price Target is $14.17 and $11 respectively.

Ironwood Pharmaceuticals, Inc. closed its last trading session at $9.8 with the gain of 0%. The Market Capitalization of the company stands at 1.55 Billion. The Company has 52-week high of $17.74 and 52-week low of $7.59. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -12.71% where SMA50 and SMA200 are -14.56% and -20.3% respectively. The Company Touched its 52-Week High on 07/13/18 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 1.81 and Average Volume (3 months) is 1.5 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 27.45.

The company shows its Return on Assets (ROA) value of -69%. The Return on Equity (ROE) value stands at 176.9%. While it’s Return on Investment (ROI) value is -109.8%.

While looking at the Stock’s Performance, Ironwood Pharmaceuticals, Inc. currently shows a Weekly Performance of -5.13%, where Monthly Performance is -14.63%, Quarterly performance is -11.37%, 6 Months performance is -3.08% and yearly performance percentage is -36.85%. Year to Date performance value (YTD perf) value is 13.01%. The Stock currently has a Weekly Volatility of 4.19% and Monthly Volatility of 4.67%.

SHARE